|
gptkbp:instanceOf
|
opioid analgesic
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:availableIn
|
liquid form
extended-release form
brand name Dilaudid
brand_name_Exalgo
|
|
gptkbp:chemicalFormula
|
liver
C17H19NO3
|
|
gptkbp:contraindication
|
asthma
severe respiratory depression
acute or severe bronchial asthma
known hypersensitivity
|
|
gptkbp:developedBy
|
gptkb:Knoll_Pharmaceuticals
|
|
gptkbp:endOfLife
|
2 to 3 hours
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Hydromorphone
|
|
gptkbp:interactsWith
|
alcohol
CNS depressants
benzodiazepines
muscle relaxants
|
|
gptkbp:isATypeOf
|
543-24-8
|
|
gptkbp:issuedBy
|
injection
oral tablet
rectal suppository
|
|
gptkbp:lastProduced
|
1926
|
|
gptkbp:offersCoursesIn
|
gptkb:Australia
gptkb:Austria
gptkb:Belgium
gptkb:Brazil
gptkb:Canada
gptkb:Denmark
gptkb:Finland
gptkb:France
gptkb:Germany
gptkb:India
gptkb:Ireland
gptkb:Italy
gptkb:Japan
gptkb:Mexico
gptkb:Netherlands
gptkb:New_Zealand
gptkb:Norway
gptkb:Portugal
gptkb:South_Africa
gptkb:Spain
gptkb:Sweden
gptkb:Switzerland
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:producedBy
|
synthesis from morphine
|
|
gptkbp:relatedTo
|
morphine
oxycodone
|
|
gptkbp:sideEffect
|
dizziness
nausea
constipation
sedation
|
|
gptkbp:usedFor
|
pain management
|
|
gptkbp:usedIn
|
palliative care
cancer pain management
postoperative pain management
|